118 related articles for article (PubMed ID: 2472484)
1. Dimethylsulfonium analogues of the muscarinic agent McN-A-343: [4-[[N-(3- or 4-halophenyl)carbamoyl]oxy]-2-butynyl] dimethylsulfonium perchlorates.
Mellin C; Vargas HM; Ringdahl B
J Med Chem; 1989 Jul; 32(7):1590-3. PubMed ID: 2472484
[TBL] [Abstract][Full Text] [Related]
2. Amide, urea, and carbamate analogues of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride.
Nilsson BM; Vargas HM; Hacksell U
J Med Chem; 1992 Jul; 35(15):2787-98. PubMed ID: 1379640
[TBL] [Abstract][Full Text] [Related]
3. [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]-trimethylammonium (McN-A-343)-related compounds. Effect of the butynyl chain inclusion into an aromatic unit on the potency for muscarinic receptors.
Tumiatti V; Angeli P; Andrisano V; Bolognesi ML; Cavalli A; Marucci G; Minarini A; Recanatini M; Rosini M; Melchiorre C
Bioorg Med Chem; 2000 Apr; 8(4):681-9. PubMed ID: 10819156
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification.
Eglen RM; Kenny BA; Michel AD; Whiting RL
Br J Pharmacol; 1987 Apr; 90(4):693-700. PubMed ID: 2437988
[TBL] [Abstract][Full Text] [Related]
5. Tertiary 2-haloethylamine derivatives of the muscarinic agent McN-A-343, [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride.
Ringdahl B; Mellin C; Ehlert FJ; Roch M; Rice KM; Jenden DJ
J Med Chem; 1990 Jan; 33(1):281-6. PubMed ID: 2296024
[TBL] [Abstract][Full Text] [Related]
6. Stereochemical analogs of a muscarinic, ganglionic stimulant. 3. 2,3-Substituted bicyclo(2.2.1)hept-5-enes and -heptanes related to 4-(N-(3-chlorophenyl)carbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343).
Nelson WL; Freeman DS; Vincenzi FF
J Med Chem; 1976 Jan; 19(1):159-60. PubMed ID: 54427
[TBL] [Abstract][Full Text] [Related]
7. Stereochemical analogs of a muscarinic, ganglionic stimulant. 2. Cis and trans olefinic, epoxide, and cyclopropane analogs related to 4-[N-(3-chlorophenyl)carbamoyloxy]-2-butynyltrimethylammonium chloride (McN-A-343).
Nelson WL; Freeman DS; Vincenzi FF
J Med Chem; 1976 Jan; 19(1):153-8. PubMed ID: 54426
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the cardiovascular responses to McN-A-343 and DMPP in pithed guinea-pigs.
Krstić MK
Neuropharmacology; 1980 Nov; 19(11):1113-8. PubMed ID: 6160424
[No Abstract] [Full Text] [Related]
9. The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart.
Birdsall NJ; Burgen AS; Hulme EC; Stockton JM; Zigmond MJ
Br J Pharmacol; 1983 Feb; 78(2):257-9. PubMed ID: 6187403
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic ganglionic stimulants: conformationally restrained analogues related to [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride.
Lambrecht G; Moser U; Mutschler E; Walther G; Wess J
J Med Chem; 1986 Jul; 29(7):1309-11. PubMed ID: 3806582
[TBL] [Abstract][Full Text] [Related]
11. Effect of tilting on the pressor responses to McN-A-343, a muscarinic sympathetic ganglion stimulant.
Fielden R; Sutton TJ; Taylor EM
Br J Pharmacol; 1980; 71(1):287-95. PubMed ID: 6162496
[TBL] [Abstract][Full Text] [Related]
12. Distinct functional muscarinic receptors in guinea-pig gallbladder, ileum and atria.
Karaalp A; Akici A; Akbulut H; Ulusoy NB; Oktay S
Pharmacol Res; 1999 May; 39(5):389-95. PubMed ID: 10328997
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the effects induced by MCN-A-343 and acetylcholine on the isolated toad rectus abdominis.
Simioni LR; Corrado AP; Jurkiewicz A
Gen Pharmacol; 1976 Aug; 7(2-3):127-32. PubMed ID: 61902
[TBL] [Abstract][Full Text] [Related]
14. Emesis induced by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343): evidence for a predominant central muscarinic M1 mediation.
Beleslin DB; Nedelkovski V
Neuropharmacology; 1988 Sep; 27(9):949-56. PubMed ID: 2460797
[TBL] [Abstract][Full Text] [Related]
15. Effects of McN-A-343, a cholinomimetic drug, on endplate currents in the frog.
Alkadhi K; Branisteanu DD; Henderson EG; Lambert JJ; Volle RL
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):117-21. PubMed ID: 6157110
[TBL] [Abstract][Full Text] [Related]
16. Modulation by the muscarinic agonist McN-A-343 of noradrenaline release from vascular sympathetic neurones.
Nedergaard OA
J Cardiovasc Pharmacol; 1980; 2(5):629-43. PubMed ID: 6157955
[No Abstract] [Full Text] [Related]
17. Receptor signaling mechanisms underlying muscarinic agonist-evoked contraction in guinea-pig ileal longitudinal smooth muscle.
Unno T; Kwon SC; Okamoto H; Irie Y; Kato Y; Matsuyama H; Komori S
Br J Pharmacol; 2003 May; 139(2):337-50. PubMed ID: 12770939
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1997 Nov; 339(2-3):153-6. PubMed ID: 9473129
[TBL] [Abstract][Full Text] [Related]
19. The design and pharmacology of novel selective muscarinic agonists and antagonists.
Lambrecht G; Gross J; Hacksell U; Hermanni U; Hildebrandt C; Hou X; Moser U; Nilsson BM; Pfaff O; Waelbroeck M
Life Sci; 1995; 56(11-12):815-22. PubMed ID: 10188780
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.
Black JW; Shankley NP
Br J Pharmacol; 1985 Nov; 86(3):609-17. PubMed ID: 2415197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
